SecSonar.com

Sanofi (SNY)

Sanofi at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Sanofi (SNY) is a Drug Manufacturers - General company based in FR with a market capitalization of $105.6B. Revenue grew 5.5% year-over-year and the company generated $11.6B in free cash flow. This page tracks SNY's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

FR · 82.88K employees · IPO Jul 1, 2002

Valuation

Valuation & price

$42.69 · as of May 17, 2026 · -18.4% vs 52w high

13.3

P/E ratio

Latest-FY diluted EPS

1.48

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$52.14$46.73$41.33Jul 25Dec 25Jul 26Jul 7, 25$48.32Jul 9, 25$48.83Jul 11, 25$48.61Jul 15, 25$48.12Jul 17, 25$48.65Jul 21, 25$47.93Jul 23, 25$50.16Jul 25, 25$50.37Jul 29, 25$49.35Jul 31, 25$45.64Aug 4, 25$48.05Aug 6, 25$46.18Aug 11, 25$47.21Aug 13, 25$48.74Aug 15, 25$49.77Aug 19, 25$50.19Aug 21, 25$50.61Aug 25, 25$50.13Aug 27, 25$50.11Aug 29, 25$49.48Sep 3, 25$49.89Sep 5, 25$46.50Sep 9, 25$47.45Sep 11, 25$47.65Sep 16, 25$46.86Sep 18, 25$47.68Sep 22, 25$47.01Sep 24, 25$46.40Sep 26, 25$45.54Sep 30, 25$47.20Oct 2, 25$50.14Oct 6, 25$49.71Oct 8, 25$48.80Oct 10, 25$48.09Oct 14, 25$49.22Oct 16, 25$50.02Oct 21, 25$49.66Oct 23, 25$49.52Oct 27, 25$51.41Oct 29, 25$50.68Oct 31, 25$50.58Nov 4, 25$49.11Nov 6, 25$49.49Nov 10, 25$50.66Nov 12, 25$51.92Nov 14, 25$52.14Nov 18, 25$50.66Nov 20, 25$48.89Nov 25, 25$50.28Nov 28, 25$49.88Dec 2, 25$49.85Dec 4, 25$48.90Dec 8, 25$48.44Dec 10, 25$48.26Dec 12, 25$48.68Dec 16, 25$47.44Dec 18, 25$47.99Dec 22, 25$48.03Dec 24, 25$48.36Dec 29, 25$48.35Jan 2, 26$48.23Jan 6, 26$48.17Jan 8, 26$48.13Jan 12, 26$47.60Jan 14, 26$47.89Jan 16, 26$46.59Jan 21, 26$46.18Jan 23, 26$47.20Jan 27, 26$47.49Jan 29, 26$46.20Feb 2, 26$47.27Feb 4, 26$48.08Feb 9, 26$48.27Feb 11, 26$49.25Feb 13, 26$46.01Feb 18, 26$46.14Feb 20, 26$46.76Feb 24, 26$47.31Feb 26, 26$48.35Mar 2, 26$47.66Mar 4, 26$46.22Mar 6, 26$44.55Mar 10, 26$43.97Mar 12, 26$43.63Mar 17, 26$44.06Mar 19, 26$45.34Mar 23, 26$44.77Mar 25, 26$46.03Mar 27, 26$46.78Mar 31, 26$48.18Apr 2, 26$47.89Apr 7, 26$46.83Apr 9, 26$47.08Apr 13, 26$46.96Apr 15, 26$48.02Apr 17, 26$48.06Apr 22, 26$46.90Apr 24, 26$46.78Apr 28, 26$45.95Apr 30, 26$46.58May 4, 26$43.35May 6, 26$43.77May 8, 26$43.31May 12, 26$42.86May 14, 26$42.85May 18, 26$43.54May 20, 26$44.67May 22, 26$44.29May 28, 26$44.29Jun 1, 26$42.96Jun 3, 26$42.37Jun 5, 26$45.02Jun 9, 26$44.73Jun 11, 26$44.11Jun 15, 26$43.80Jun 17, 26$42.50Jun 22, 26$41.78Jun 24, 26$41.33Jun 26, 26$42.95Jul 2, 26$43.16
$41.3352-week range$52.34
Loading valuation history…

Fundamentals

Key fundamentals

$105.6B

Market cap

5.5%

Revenue growth (YoY)

72.1%

Gross margin

$11.6B

Free cash flow (USD)

$14.1B

Net debt

-2.5%

Share dilution

4/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$34.7BFY 2017$36.2BFY 2018$35.7BFY 2019$37.6BFY 2020$37.4BFY 2021$39.2BFY 2022$40.6BFY 2023$41.6BFY 2024$44.3BFY 2025$46.7B
$34.7B$46.7B

Free cash flow by year

2016 → 2025

FY 2016$5.8BFY 2017$5.4BFY 2018$3.6BFY 2019$5.9BFY 2020$5.3BFY 2021$8.5BFY 2022$8.3BFY 2023$8.6BFY 2024$5.9BFY 2025$10.1B
$5.8B$10.1B

Gross margin by year

2021 → 2025

FY 202168.7%FY 202270.7%FY 202369.7%FY 202470.2%FY 202572.1%
68.7%72.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed Apr 23, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingRegulatory ApprovalJun 24, 2026Filing
  • 6-K filingRegulatory UpdateJun 22, 2026Filing
  • 6-K filingRegulatory UpdateJun 12, 2026Filing
  • 6-K filingRegulatory UpdateJun 8, 2026Filing
  • 6-K filingPhase 2 Study ResultsMay 27, 2026Filing
  • 6-K filingManagement ChangeMay 5, 2026Filing
  • 6-K filingBond Issue PricedApr 29, 2026Filing
  • 6-K filingFDA Approval AnnouncementApr 27, 2026Filing
  • Quarterly reportQuarterly Report FiledApr 23, 2026Filing
  • 6-K filingRegulatory UpdateApr 15, 2026Filing

Questions

Frequently asked questions

What is Sanofi's market cap?

Sanofi (SNY) has a market capitalization of $105.6B.

What is SNY's P/E ratio?

SNY trades at a price-to-earnings ratio of 13.3, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is SNY's price-to-book (P/B) ratio?

SNY trades at 1.48 times book value per share.

Are insiders buying SNY stock?

SEC Form 4 filings show no open-market insider buys at Sanofi in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - General

GSK

GSK plc

$101.9B

PFE

Pfizer Inc.

$148.6B

GILD

Gilead Sciences, Inc.

$167.4B

ZTS

Zoetis Inc.

$32.6B

AMGN

Amgen Inc.

$180.9B

BIIB

Biogen Inc.

$29.2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.